• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

MERS serological study - Saudi Arabia

Shannon Bennett

Well-known member
[h=1]Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study[/h]

[h=4]Findings[/h] Between Dec 1, 2012, and Dec 1, 2013, we obtained individual serum samples from 10 009 individuals. Anti-MERS-CoV antibodies were confirmed in 15 (0?15%; 95% CI 0?09?0?24) of 10 009 people in six of the 13 provinces. The mean age of seropositive individuals was significantly younger than that of patients with reported, laboratory-confirmed, primary Middle Eastern respiratory syndrome (43?5 years [SD 17?3] vs 53?8 years [17?5]; p=0?008). Men had a higher antibody prevalence than did women (11 [0?25%] of 4341 vs two [0?05%] of 4378; p=0?028) and antibody prevalence was significantly higher in central versus coastal provinces (14 [0?26%] of 5479 vs one [0?02%] of 4529; p=0?003). Compared with the general population, seroprevalence of MERS-CoV antibodies was significantly increased by 15 times in shepherds (two [2?3%] of 87, p=0?0004) and by 23 times in slaughterhouse workers (five [3?6%] of 140; p<0?0001).
[h=4]Interpretation[/h] Seroprevalence of MERS-CoV antibodies was significantly higher in camel-exposed individuals than in the general population. By simple multiplication, a projected 44 951 (95% CI 26 971?71 922) individuals older than 15 years might be seropositive for MERS-CoV in Saudi Arabia. These individuals might be the source of infection for patients with confirmed MERS who had no previous exposure to camels.


http://www.sciencedirect.com/science/article/pii/S1473309915700903
 
http://www.cidrap.umn.edu/news-persp...ers-infections Saudi serology study shows possible role for silent MERS infections

Excerpt


Filed Under:
MERS-CoV



Lisa Schnirring | Staff Writer | CIDRAP News


| Apr 09, 2015

The team concluded that middle-aged men who have regular contact with camels may sporadically transmit the virus to the general population, and the subclinical or mild infections &#151;especially in younger people &#151;might be the source of unknown sources of exposure reported for many MERS patients.

The researchers noted that antibodies were seen across a wide part of Saudi Arabia, even in areas that haven't reported outbreaks. Extrapolating their findings to the general population, they estimated that as many as 44,951 people in Saudi Arabia may have MERS-CoV antibodies, though Drosten in last month's Science story called the extrapolation "a bit risky."
 
Back
Top